



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Monday,
                        11 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)






                                    LOK SABHA
                                





STARRED   


                                    QUESTION NO:
                                

256






                                    ANSWERED ON: 
                                

12.03.2021






Quality of Ayurvedic Medicines




Ajay Bhatt














                        Will the Minister of





AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)


                        be pleased to state:-















                                                    Will the Minister of  AYURVEDA, YOGA AND NATUROPATHY,UNANI, SIDDHA AND HOMOEOPATHY (AYUSH) be pleased to state: (a) whether the Government proposes to formulate guidelines on Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) for compliance by units manufacturing Ayurvedic medicines, on the lines of Allopathy; (b) if so, the details thereof; (c) the steps taken by the Government to check the use of heavy metals and other harmful ingredients in Ayurvedic medicines; and (d) the other steps taken including the mechanism set up to improve the efficacy/quality of Ayurvedic medicines?






ANSWER




                                                        (a)	to (d):  A statement is laid on the Table of the House STATEMENT REFERRED TO IN REPLY TO LOK SABHASTARRED QUESTION NO. 256 * FOR 12TH  MARCH, 2021(a) & (b)   As per the provisions of Rule 157(1) of Drugs and Cosmetics Rules, 1945, the manufacture of Ayurvedic (Including Siddha) or Unani drugs are to be carried out in such premises and such hygienic conditions as are specified in Schedule-T (Good Manufacturing Practices). It is mandatory for the manufacturers to comply with GMP for obtaining license of Ayurveda, Siddha and Unani (ASU) drug manufacturing.There are no separate guidelines of Good Laboratory Practice (GLP) for Ayurvedic Medicines. However under Rule 160 A to J of Drug & Cosmetics Rules 1945, there are provisions for approval of laboratories for carrying out tests on Ayurvedic drugs and raw materials.(c) As per Drugs & Cosmetics Act 1940 and Rules made thereunder, it is mandatory for all Ayurvedic medicines to comply with the standards prescribed under Ayurvedic Pharmacopeia of India (API), published by Ministry of AYUSH, Government of India from time to time, which includes pharmacopoeial standards for heavy metals content, microbiological limits, aflatoxins etc. and products are tested against the set standards.  However, heavy metals are in built ingredients of certain ASU drugs and mentioned under Schedule E-1 of the Drugs & Cosmetics Rules, 1945. For such substances, ‘Caution: to be taken under medical supervision’ is to be conspicuously labeled on the container.An advisory has been issued on 14th October, 2005 by this Ministry which prescribes limit and testing of heavy metals mandatory for export purposes in respect of every batch of purely herbal ASU drugs by every licensee.  (d) Ministry of AYUSH has a Central Sector Scheme of Pharmacovigilance of Ayurveda, Siddha Unani & Homeopathy Drugs already functional since June 2018 for inculcating the culture of Adverse Drug Events (ADE) reporting, documentation and analysis for further regulatory action. The Scheme has an established three tier network. All India Institute of Ayurveda (AIIA), New Delhi, has been designated as the National Pharmacovigilance Coordination Centre (NPvCC), 5 Intermediary Pharmacovigilance  Centres (IPvC’s) and 74 Peripheral Pharmacovigilance Centres (PPvC’s).Rule 158B in the Drugs & Cosmetics Act Rules, 1945, has mandatory provision relating to safety study and the experience or evidence of effectiveness for issuing license to ASU drugs. The Government has established Pharmacopoeia Commission for Indian Medicine and Homoeopathy under the Ministry of AYUSH. The prime mandate of the Commission is to publish and revise Ayurvedic Pharmacopoeia of India (API), Siddha Pharmacopoeia of India (SPI), Unani Pharmacopoeia of India (UPI) and Homoeopathic Pharmacopoeia of India (HPI). The Pharmacopoeial standards are basic need to ensure quality, safety and efficacy of Ayurvedic, Siddha, Unani and Homoeopathic medicines. ******
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113206722







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







